NP / PA
Frueh, Danielle
Frueh, Danielle was paid $95K by Medicaid between Jun 2024 and Dec 2024, across 19 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoFRUEH, DANIELLE
SHILOH, IL 62269
SHILOH, IL 62269
33aNPI1013524487assigned 09/29/2020
33bProvider typeFamily Nurse Practitioner
28Total paid$95K
24GClaims2,980
24DCodes billed19
24AFirst – last monthJun 2024 – Dec 2024
Compared with peers
Next to other Family Nurse Practitioner providers in Illinois
Rank by total paid#780 of 3,353
Median peer was paid$25K
This provider vs. median3.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 2,980 | $95K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 454 | 403 | $34K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13% | 359 | 258 | $13K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13% | 359 | 258 | $13K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 9.6% | 323 | 224 | $9K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 5.2% | 64 | 59 | $5K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 4.9% | 175 | 144 | $5K |
| 96127 | 2.7% | 177 | 145 | $3K | |
| 99459 | 2.5% | 173 | 168 | $2K | |
| 86780 | 2.5% | 176 | 144 | $2K | |
| 86803 | 2.3% | 153 | 120 | $2K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1.9% | 25 | 18 | $2K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.7% | 33 | 26 | $2K |
7 more codes
| 87340 | 1.6% | 152 | $2K | |
| 81025 | <1% | 147 | $823.88 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 108 | $619.92 |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 19 | $544.54 |
| 86762 | <1% | 35 | $352.45 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 36 | $244.80 |
| 96160 | <1% | 12 | $175.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.